BIO Applauds Advancement of biomedical innovation legislation.

Press Release Summary:



BIO's Jim Greenwood, in his statement regarding Senate HELP Committee mark-up of legislation as part of Senate biomedical innovation initiative, applauded bipartisan votes. Specifically, Greenwood cited passage of The Advancing Hope Act of 2015, reauthorizing Pediatric Rare Disease Priority Review Voucher Program. He also spoke to passing of Medical Countermeasures Innovation Act of 2015 as well as legislation adding Zika virus to Tropical Disease Priority Review Voucher program.



Original Press Release:



BIO Applauds Advancement of Senate Biomedical Innovation Legislation



Washington, D.C. – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative:



“BIO applauds today’s bipartisan votes by the Senate HELP Committee to advance legislation as part of the Senate biomedical innovation initiative. In particular, BIO applauds the Committee’s passage of The Advancing Hope Act of 2015, reauthorizing the Pediatric Rare Disease Priority Review Voucher Program, which provides an important incentive for companies developing treatments for rare pediatric diseases. We were also pleased that the Committee passed legislation to add the Zika virus to the Tropical Disease Priority Review Voucher program.



“BIO was very encouraged that the Committee passed the Medical Countermeasures Innovation Act of 2015, addressing a number of contracting and regulatory challenges and incentivizing further research and development of critical medical countermeasures products.



“BIO and our members have been engaged throughout this bipartisan process, and we look forward to working with members of the Committee on common sense reforms that will improve the entire ecosystem of innovation which patients rely upon to deliver new treatments. We thank Chairman Alexander, Ranking Member Murray and all members of the Committee for their commitment to this important work.”



Upcoming BIO Events



BIO International Convention

June 6-9, 2016

San Francisco, Calif.



13th Annual BIO Asia International Conference

March 15-16, 2016

Tokyo, Japan



BIO-Europe Spring

April 4-6, 2016

Stockholm, Sweden



About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

All Topics